Peptide Therapeutics Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2028

Published Date : Nov 2020 | No. of Pages : 200 Pages | Category : Healthcare

According to Vision Research Reports, the global peptide therapeutics market size surpassed at US$ 25.6 Bn in 2020 and is expected to grow at a CAGR of 8.3% from 2021 to 2028.

Global peptide therapeutics market size is projected to surpass around US$ 50 billion by 2028, high incidence & prevalence of metabolic disorders to escalate the growth of global peptide therapeutics market. moreover, advances in drug delivery and bioavailability is projected to drive the global peptide therapeutics market during the forecast period.

Overview

  • Peptides are the combination of two or more amino acid monomers linked by amide bonds. Researchers has demonstrated that peptide are distinguished from proteins on the basis of size. As a benchmark, molecules with less than 50 amino acids are considered as peptides. Peptides act by binding to specific cell surface receptors and mimics like receptor ligands and help in treatment of diseases by acting on the cell membrane.
  • The peptide therapeutics market is currently a booming one, since there has been a decline in non-peptide chemical drugs available in the market. Rise in the patent cliff has anticipated for the growth of the peptides generics market. The CMOs which provide end-to-end service to the biotech pharmaceutical companies are growing due to shift in focus of pharma companies to explore better opportunities in the peptide therapeutics market. Peptides initially had applications only in diagnostics and hormonal therapy; however, with advances in technology, peptides are now being widely applied for therapeutic applications of cancer and chronic metabolic diseases.
  • North America dominate the global peptide therapeutics market in 2020 and the trend is anticipated to continue during the forecast period. Well established healthcare infrastructure, high priced peptide therapeutics drugs and favorable reimbursement policies and structure accentuate peptide therapeutics market growth in the region.
  • Asia Pacific is likely to be a highly lucrative market for the peptide therapeutics market and it is expected to expand at a high CAGR during the forecast period. Vast patient pool, increasing healthcare expenditure and demand for newer advanced therapies are key factors likely to boost peptide therapeutics market in Asia Pacific.

Surge in Number of Cancer and Other Chronic Disease Patients to Drive Global Peptide Therapeutics Market

  • Cancer is the leading cause of death globally. For instance,  according to GLOBOCAN 2018, in 2018, 3,792,000 number of cancer cases in the Americas, 4,230,000 number of cases in Europe and 8,751,000 cases in Asia
  • Chemotherapy, which is the major mode of treatment for cancer, is facing major challenges due to its inability to deliver the correct amount of drug directly. In addition, it affects the normal cells in the body. Therapeutics peptides application in cancer treatment has opened a promising avenue for future growth of peptide therapeutics market
  • Besides, surge in prevalence and incidence rate of other chronic conditions such as diabetes, cardiac diseases and immune disorders, owing to increasing geriatric population is projected to propel the global peptide therapeutics market.

Cancer Segment to Dominate Peptide Therapeutics Market

  • In terms of application, the global peptide therapeutics market has been segmented into cancer, metabolic, CVD, respiratory, GIT, anti-infective, dermatology, CNS, and renal. The cancer segment dominated the global peptide therapeutics market in 2020 and the trend is projected to continue during the forecast period. Rising mortality due to cancer has led to an increase in focus for the development of new drugs and products to combat the situation

Parenteral Segment Hold a Major Share of Global Peptide Therapeutics Market

  • In terms of route of administration, the global peptide therapeutics market has been classified into parenteral, oral and others.
  • The parenteral segment dominated the peptide therapeutics market. The parenteral route of administration is the most common as it ensures faster and better bioavailability, faster onset time and better treatment outcomes. However, with advances in drug delivery technologies there has been a change in the trend of route of administration of therapeutic peptides.

Innovative Therapeutics Peptides to Dominate Global Peptide Therapeutics Market

  • Based on type, the global peptide therapeutics market has been segmented into innovative and generic. The innovative segment dominated the global peptide therapeutics market in 2020 and the trend is projected to continue during the forecast period. Extensive R&D activities adopted by market players are expected to propel the market growth at an outstanding rate.
  • However, expiry of market exclusivity of blockbuster peptide therapeutics drugs over the forecast period is likely to have an impact on the global peptide therapeutics market.

Immunopeptides Segment to exhibit Rapid Growth in Global Peptide Therapeutics Market

  • In terms of molecule, Immunopeptide segment is likely to grow at rapid pace during the forecast period owing to rise in use of immunopeptides in the drugs for treatment of cancer and tumors. High prevalence of cancer and surge in incidence rate of new cancer cases is likely to drive immunopeptides market during the forecast period.
  • Other peptide therapeutic drugs which are recently introduced or are in late phase of clinical trials are projected to withhold significant share of global peptide therapeutics market by the end of forecast period.

North America to Dominate Global Peptide Therapeutics Market

  • In terms of region, the global peptide therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global peptide therapeutics market in 2020, followed by Europe.
  • North America accounted for major share of the global peptide therapeutics market in 2020. High disease prevalence, supportive healthcare and payer infrastructure, and hub for key industry players are the major drivers of the peptide therapeutics market in the region.
  • The peptide therapeutics market in Asia Pacific is anticipated to expand at a high CAGR from 2021 to 2028. Unmet medical needs, untapped nature of the market, huge investment by players, and rise in health care infrastructure are the key factors for market growth in the region

Competitive Landscape

  • The global peptide therapeutics market is fragmented in terms of number of players. Key players in the global peptide therapeutics market include Amgen, Inc., Bachem Holding AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Novartis AG, Pfizer, Inc., Sanofi, Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd.

Market Segmentation

By Application

    • Cancer
    • Metabolic
    • CVD
    • Respiratory
    • GIT
    • Anti-infective
    • Dermatology
    • CNS
    • Renal

By Route of Administration

    • Parenteral
    • Oral

By Type

    • Innovative
    • Generic

By Technology

    • Liquid Phase
    • Solid Phase,
    • Hybrid Phase

By Type of Molecule

    • Vasopressin
    • Somatostatin
    • Calcitonin
    • Natriuretic
    • Immunopeptide

By API Peptide Type

    • In-house
    • CMO

By Region

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific          
      • China
      • India
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East & Africa

Report Scope

The Peptide therapeutics market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Peptide therapeutics market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Peptide therapeutics market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Peptide therapeutics market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Peptide therapeutics market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Peptide therapeutics capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Peptide therapeutics by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Peptide therapeutics market. These figures have been provided in terms of both revenue and volume for the period 2016 to 2027. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Peptide therapeutics market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Peptide therapeutics market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Peptide therapeutics industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

Peptide therapeutics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Peptide therapeutics market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Peptide therapeutics market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Peptide therapeutics market. These factors have benefited the growth of the global market for Peptide therapeutics. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Peptide therapeutics. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Peptide therapeutics are as follows:

  • History Year: 2017-2020
  • Base Year: 2020
  • Forecast Year 2021 to 2028

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2028);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Featured Research Reports

  • Featured Research Reports

    Depth of Anesthesia Monitoring Devices Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Tissue Processing Systems Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    PACS and RIS Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Unfractionated Heparin Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

    Read more...
  • Featured Research Reports

    Hydrocortisone Market Size, Share, Growth, Trends, Consumption, Revenue, Company Analysis, Regional Insights and Forecast 2021-2030

    Read more...